{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:51:45Z","timestamp":1783461105344,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Central South University graduate students independent exploration and innovation project","award":["1053320222011"],"award-info":[{"award-number":["1053320222011"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171118"],"award-info":[{"award-number":["82171118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2021JJ41027"],"award-info":[{"award-number":["2021JJ41027"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04103-3","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:37:42Z","timestamp":1765197462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell sequencing reveals MCAM+ MyCAFs as key pro-angiogenic cells interacting with endothelial cells in solid-type adenoid cystic carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaotian","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"7","key":"4103_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.oraloncology.2015.04.005","volume":"51","author":"A Coca-Pelaz","year":"2015","unstructured":"Coca-Pelaz A, Rodrigo JP, Bradley PJ, et al. Adenoid cystic carcinoma of the head and neck\u2013an update. Oral Oncol. 2015;51(7):652\u201361. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.04.005.","journal-title":"Oral Oncol"},{"issue":"5","key":"4103_CR2","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.ijrobp.2018.12.009","volume":"103","author":"RL Bakst","year":"2019","unstructured":"Bakst RL, Glastonbury CM, Parvathaneni U, Katabi N, Hu KS, Yom SS. Perineural invasion and perineural tumor spread in head and neck cancer. Int J Radiat Oncol Biol Phys. 2019;103(5):1109\u201324. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.12.009.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4103_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12105-017-0795-0","volume":"11","author":"RR Seethala","year":"2017","unstructured":"Seethala RR, Stenman G. Update from the 4th edition of the world health organization classification of head and neck tumours: tumors of the salivary gland. Head Neck Pathol. 2017;11(1):55\u201367. https:\/\/doi.org\/10.1007\/s12105-017-0795-0.","journal-title":"Head Neck Pathol"},{"issue":"1","key":"4103_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s43046-022-00144-1","volume":"34","author":"MC Balakrishnan","year":"2022","unstructured":"Balakrishnan MC, Bhatia A, Lyngdoh BS, Harris C, Lynser D, Kalita P. High-grade transformation of adenoid cystic carcinoma of parotid gland with isolated intratemporal facial nerve involvement: a case report and literature review. J Egypt Natl Cancer Inst. 2022;34(1):39. https:\/\/doi.org\/10.1186\/s43046-022-00144-1.","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"7","key":"4103_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/0284186X.2018.1426878","volume":"57","author":"JM Ryckman","year":"2018","unstructured":"Ryckman JM, Kusi Appiah A, Simone CB, Verma V. Treatment approaches for nasopharyngeal adenoid cystic carcinoma. Acta Oncol. 2018;57(7):995\u20131001. https:\/\/doi.org\/10.1080\/0284186X.2018.1426878.","journal-title":"Acta Oncol"},{"key":"4103_CR6","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2147\/CMAR.S355663","volume":"14","author":"S Atallah","year":"2022","unstructured":"Atallah S, Marc M, Schernberg A, et al. Beyond surgical treatment in adenoid cystic carcinoma of the head and neck: a literature review. Cancer Manag Res. 2022;14:1879\u201390. https:\/\/doi.org\/10.2147\/CMAR.S355663.","journal-title":"Cancer Manag Res"},{"issue":"10","key":"4103_CR7","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1093\/annonc\/mdw287","volume":"27","author":"AL Ho","year":"2016","unstructured":"Ho AL, Dunn L, Sherman EJ, et al. A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma. Ann Oncol. 2016;27(10):1902\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdw287.","journal-title":"Ann Oncol"},{"issue":"18","key":"4103_CR8","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1200\/JCO.18.01859","volume":"37","author":"V Tchekmedyian","year":"2019","unstructured":"Tchekmedyian V, Sherman EJ, Dunn L, et al. Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma. J Clin Oncol. 2019;37(18):1529\u201337. https:\/\/doi.org\/10.1200\/JCO.18.01859.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4103_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrd3455","volume":"10","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011;10(6):417\u201327. https:\/\/doi.org\/10.1038\/nrd3455.","journal-title":"Nat Rev Drug Discov"},{"issue":"15","key":"4103_CR10","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-10-0153","volume":"70","author":"RK Shrimali","year":"2010","unstructured":"Shrimali RK, Yu Z, Theoret MR, Chinnasamy D, Restifo NP, Rosenberg SA. Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Cancer Res. 2010;70(15):6171\u201380. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0153.","journal-title":"Cancer Res"},{"issue":"15","key":"4103_CR11","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1200\/JCO.22.02221","volume":"41","author":"R Ferrarotto","year":"2023","unstructured":"Ferrarotto R, Sousa LG, Feng L, et al. Phase II clinical trial of axitinib and avelumab in patients with recurrent\/metastatic adenoid cystic carcinoma. J Clin Oncol. 2023;41(15):2843\u201351. https:\/\/doi.org\/10.1200\/JCO.22.02221.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4103_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cas.15609","volume":"114","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto Y, Kasashima H, Fukui Y, Tsujio G, Yashiro M, Maeda K. The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment. Cancer Sci. 2023;114(1):16\u201324. https:\/\/doi.org\/10.1111\/cas.15609.","journal-title":"Cancer Sci"},{"issue":"5","key":"4103_CR13","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3390\/cancers12051307","volume":"12","author":"A Sebastian","year":"2020","unstructured":"Sebastian A, Hum NR, Martin KA, et al. Single-cell transcriptomic analysis of tumor-derived fibroblasts and normal tissue-resident fibroblasts reveals fibroblast heterogeneity in breast cancer. Cancers. 2020;12(5):1307. https:\/\/doi.org\/10.3390\/cancers12051307.","journal-title":"Cancers"},{"issue":"5","key":"4103_CR14","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","volume":"73","author":"M Zhang","year":"2020","unstructured":"Zhang M, Yang H, Wan L, et al. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. J Hepatol. 2020;73(5):1118\u201330. https:\/\/doi.org\/10.1016\/j.jhep.2020.05.039.","journal-title":"J Hepatol"},{"issue":"1","key":"4103_CR15","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","volume":"9","author":"M Bartoschek","year":"2018","unstructured":"Bartoschek M, Oskolkov N, Bocci M, et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018;9(1):5150. https:\/\/doi.org\/10.1038\/s41467-018-07582-3.","journal-title":"Nat Commun"},{"issue":"3","key":"4103_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","volume":"41","author":"G Caligiuri","year":"2023","unstructured":"Caligiuri G, Tuveson DA. Activated fibroblasts in cancer: perspectives and challenges. Cancer Cell. 2023;41(3):434\u201349. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.015.","journal-title":"Cancer Cell"},{"issue":"16","key":"4103_CR17","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1158\/1078-0432.CCR-23-0514","volume":"29","author":"LG Sousa","year":"2023","unstructured":"Sousa LG, McGrail DJ, Lazar Neto F, et al. Spatial immunoprofiling of adenoid cystic carcinoma reveals B7-H4 is a therapeutic target for aggressive tumors. Clin Cancer Res. 2023;29(16):3162\u201371. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0514.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4103_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000091097","volume":"181","author":"A Wenger","year":"2005","unstructured":"Wenger A, Kowalewski N, Stahl A, et al. Development and characterization of a spheroidal coculture model of endothelial cells and fibroblasts for improving angiogenesis in tissue engineering. Cells Tissues Organs. 2005;181(2):80\u20138. https:\/\/doi.org\/10.1159\/000091097.","journal-title":"Cells Tissues Organs"},{"issue":"Pt 4","key":"4103_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1242\/jcs.105.4.1013","volume":"105","author":"R Montesano","year":"1993","unstructured":"Montesano R, Pepper MS, Orci L. Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts. J Cell Sci. 1993;105(Pt 4):1013\u201324. https:\/\/doi.org\/10.1242\/jcs.105.4.1013.","journal-title":"J Cell Sci"},{"key":"4103_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.877219","volume":"12","author":"LA Al-Kharashi","year":"2022","unstructured":"Al-Kharashi LA, Tulbah A, Arafah M, Eldali AM, Al-Tweigeri T, Aboussekhra A. High DNMT1 expression in stromal fibroblasts promotes angiogenesis and unfavorable outcome in locally advanced breast cancer patients. Front Oncol. 2022;12:877219. https:\/\/doi.org\/10.3389\/fonc.2022.877219.","journal-title":"Front Oncol"},{"issue":"20","key":"4103_CR21","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1091\/mbc.E11-05-0393","volume":"22","author":"AC Newman","year":"2011","unstructured":"Newman AC, Nakatsu MN, Chou W, Gershon PD, Hughes CCW. The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol Biol Cell. 2011;22(20):3791\u2013800. https:\/\/doi.org\/10.1091\/mbc.E11-05-0393.","journal-title":"Mol Biol Cell"},{"issue":"11","key":"4103_CR22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1046\/j.1365-2362.2001.00914.x","volume":"31","author":"TA Martin","year":"2001","unstructured":"Martin TA, Harding K, Jiang WG. Matrix-bound fibroblasts regulate angiogenesis by modulation of VE-cadherin. Eur J Clin Invest. 2001;31(11):931\u20138. https:\/\/doi.org\/10.1046\/j.1365-2362.2001.00914.x.","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"4103_CR23","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3390\/cancers14102406","volume":"14","author":"J Ma","year":"2022","unstructured":"Ma J, Chen X, Chen Y, Tao N, Qin Z. Ligustilide inhibits tumor angiogenesis by downregulating VEGFA secretion from cancer-associated fibroblasts in prostate cancer via TLR4. Cancers. 2022;14(10):2406. https:\/\/doi.org\/10.3390\/cancers14102406.","journal-title":"Cancers"},{"issue":"1","key":"4103_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijo.2021.5293","volume":"60","author":"K Watanabe","year":"2022","unstructured":"Watanabe K, Shiga K, Maeda A, et al. Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer. Int J Oncol. 2022;60(1):3. https:\/\/doi.org\/10.3892\/ijo.2021.5293.","journal-title":"Int J Oncol"},{"issue":"4","key":"4103_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s13402-018-0371-y","volume":"41","author":"N Eiro","year":"2018","unstructured":"Eiro N, Gonz\u00e1lez L, Mart\u00ednez-Ordo\u00f1ez A, et al. Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis. Cell Oncol. 2018;41(4):369\u201378. https:\/\/doi.org\/10.1007\/s13402-018-0371-y.","journal-title":"Cell Oncol"},{"key":"4103_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.616576","volume":"11","author":"Y Xu","year":"2021","unstructured":"Xu Y, Jiang E, Shao Z, Shang Z. LncRNA fendrr in carcinoma-associated fibroblasts regulates the angiogenesis of oral squamous cell carcinoma through the PI3K\/AKT pathway. Front Oncol. 2021;11:616576. https:\/\/doi.org\/10.3389\/fonc.2021.616576.","journal-title":"Front Oncol"},{"issue":"11","key":"4103_CR27","doi-asserted-by":"publisher","first-page":"e31584","DOI":"10.1016\/j.heliyon.2024.e31584","volume":"10","author":"N Payervand","year":"2024","unstructured":"Payervand N, Pakravan K, Razmara E, et al. Exosomal circ_0084043 derived from colorectal cancer-associated fibroblasts promotes in vitro endothelial cell angiogenesis by regulating the miR-140-3p\/HIF-1\u03b1\/VEGF signaling axis. Heliyon. 2024;10(11):e31584. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31584.","journal-title":"Heliyon"},{"issue":"1","key":"4103_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/jgh.16345","volume":"39","author":"J Zhang","year":"2024","unstructured":"Zhang J, Pan Y, Jin L, Yang H, Cao P. Exosomal-miR-522-3p derived from cancer-associated fibroblasts accelerates tumor metastasis and angiogenesis via repression bone morphogenetic protein 5 in colorectal cancer. J Gastroenterol Hepatol. 2024;39(1):107\u201320. https:\/\/doi.org\/10.1111\/jgh.16345.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"4103_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/jop.12452","volume":"46","author":"NN Lin","year":"2017","unstructured":"Lin NN, Wang P, Zhao D, Zhang FJ, Yang K, Chen R. Significance of oral cancer-associated fibroblasts in angiogenesis, lymphangiogenesis, and tumor invasion in oral squamous cell carcinoma. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2017;46(1):21\u201330. https:\/\/doi.org\/10.1111\/jop.12452.","journal-title":"J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"issue":"3","key":"4103_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/PAP.0000000000000298","volume":"28","author":"A Skalova","year":"2021","unstructured":"Skalova A, Leivo I, Hellquist H, et al. High-grade transformation\/dedifferentiation in salivary gland carcinomas: occurrence across subtypes and clinical significance. Adv Anat Pathol. 2021;28(3):107\u201318. https:\/\/doi.org\/10.1097\/PAP.0000000000000298.","journal-title":"Adv Anat Pathol"},{"key":"4103_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ijscr.2020.12.014","volume":"78","author":"B Ahlem","year":"2021","unstructured":"Ahlem B, Manel N, Nouha BA, et al. High grade transformation of adenoid cystic carcinoma in the palate: case report with review of literature. Int J Surg Case Rep. 2021;78:162\u20136. https:\/\/doi.org\/10.1016\/j.ijscr.2020.12.014.","journal-title":"Int J Surg Case Rep"},{"issue":"1","key":"4103_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13041-021-00892-6","volume":"15","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhao Y. Progress on the roles of MEF2C in neuropsychiatric diseases. Mol Brain. 2022;15(1):8. https:\/\/doi.org\/10.1186\/s13041-021-00892-6.","journal-title":"Mol Brain"},{"issue":"1","key":"4103_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM. Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77(1):43\u201351. https:\/\/doi.org\/10.1016\/j.biopsych.2014.05.006.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"4103_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1919","volume":"10","author":"JA Cooley Coleman","year":"2022","unstructured":"Cooley Coleman JA, Sarasua SM, Moore HW, et al. Clinical findings from the landmark MEF2C-related disorders natural history study. Mol Genet Genomic Med. 2022;10(6):e1919. https:\/\/doi.org\/10.1002\/mgg3.1919.","journal-title":"Mol Genet Genomic Med"},{"issue":"3","key":"4103_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","volume":"142","author":"M Ieda","year":"2010","unstructured":"Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010;142(3):375. https:\/\/doi.org\/10.1016\/j.cell.2010.07.002.","journal-title":"Cell"},{"issue":"3","key":"4103_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/CIRCULATIONAHA.121.058655","volume":"147","author":"H Tani","year":"2023","unstructured":"Tani H, Sadahiro T, Yamada Y, et al. Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction. Circulation. 2023;147(3):223\u201338. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.058655.","journal-title":"Circulation"},{"issue":"9","key":"4103_CR37","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1158\/1078-0432.CCR-20-4226","volume":"27","author":"PM Galbo","year":"2021","unstructured":"Galbo PM, Zang X, Zheng D. Molecular features of cancer-associated fibroblast subtypes and their implication on cancer pathogenesis, prognosis, and immunotherapy resistance. Clin Cancer Res. 2021;27(9):2636\u201347. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4226.","journal-title":"Clin Cancer Res"},{"key":"4103_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101790","volume":"38","author":"H Chen","year":"2023","unstructured":"Chen H, Yang W, Ma L, Li Y, Ji Z. Machine-learning based integrating bulk and single-cell RNA sequencing reveals the SLC38A5-CCL5 signaling as a promising target for clear cell renal cell carcinoma treatment. Transl Oncol. 2023;38:101790. https:\/\/doi.org\/10.1016\/j.tranon.2023.101790.","journal-title":"Transl Oncol"},{"issue":"22","key":"4103_CR39","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1242\/dev.125.22.4565","volume":"125","author":"Q Lin","year":"1998","unstructured":"Lin Q, Lu J, Yanagisawa H, et al. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development. 1998;125(22):4565\u201374. https:\/\/doi.org\/10.1242\/dev.125.22.4565.","journal-title":"Development"},{"issue":"2","key":"4103_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1006\/bbrc.2001.5589","volume":"287","author":"BM Hosking","year":"2001","unstructured":"Hosking BM, Wang SC, Chen SL, Penning S, Koopman P, Muscat GE. SOX18 directly interacts with MEF2C in endothelial cells. Biochem Biophys Res Commun. 2001;287(2):493\u2013500. https:\/\/doi.org\/10.1006\/bbrc.2001.5589.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"4103_CR41","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1167\/iovs.08-1760","volume":"49","author":"D Maiti","year":"2008","unstructured":"Maiti D, Xu Z, Duh EJ. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells. Invest Ophthalmol Vis Sci. 2008;49(8):3640\u20138. https:\/\/doi.org\/10.1167\/iovs.08-1760.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"4103_CR42","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","volume":"79","author":"CH Heldin","year":"1999","unstructured":"Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79(4):1283\u2013316. https:\/\/doi.org\/10.1152\/physrev.1999.79.4.1283.","journal-title":"Physiol Rev"},{"issue":"8","key":"4103_CR43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrc2894","volume":"10","author":"H Huang","year":"2010","unstructured":"Huang H, Bhat A, Woodnutt G, Lappe R. Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer. 2010;10(8):575\u201385. https:\/\/doi.org\/10.1038\/nrc2894.","journal-title":"Nat Rev Cancer"},{"key":"4103_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-11-97","volume":"11","author":"CH Heldin","year":"2013","unstructured":"Heldin CH. Targeting the PDGF signaling pathway in tumor treatment. Cell Commun Signal. 2013;11:97. https:\/\/doi.org\/10.1186\/1478-811X-11-97.","journal-title":"Cell Commun Signal"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04103-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:04:48Z","timestamp":1768341888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-025-04103-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4103"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04103-3","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Xiangya hospital Research Ethics Committee of the Central South University. The patients\/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All information was collected with the consent of the patient and approved by our institutional ethics department.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}